Litigation
class action litigation 2020
Supplement RegulationsCV Sciences temporarily spared from lawsuit pending FDA rulemakingCV Sciences temporarily spared from lawsuit pending FDA rulemaking
A federal judge recently stayed a lawsuit against CV Sciences while FDA continues to look into regulating the CBD market.
Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.